The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > Nucleocapsid

Nucleocapsid

The nucleocapsid, or N protein, is a key structural component of viruses, including SARS-CoV-2, the virus that causes COVID-19.
It encapsulates the viral genome and plays a crucial role in viral assembly and replication.
Researchers studying the nucleocapsid can leverage PubCompare.ai's tools to streamline their workflows, locating relevant protocols from literature, preprints, and patents, and using AI-driven comparisons to identify the most reproducible and accruate methods.
This can help optimize nucleocapsid analysis and enhance overall research productivity.

Most cited protocols related to «Nucleocapsid»

For the newly identified virus genome, the potential ORFs were predicted and annotated using the conserved signatures of the cleavage sites recognized by coronavirus proteinases, and were processed in the Lasergene software package (v.7.1, DNAstar). The viral genes were aligned using the L-INS-i algorithm implemented in MAFFT (v.7.407)37 (link).
Phylogenetic analyses were then performed using the nucleotide sequences of various CoV gene datasets: (1) whole genome, (2) ORF1a, (3) ORF1b, (4) nsp5 (3CLpro), (5) RdRp (nsp12), (6) nsp13 (Hel), (7) nsp14 (ExoN), (8) nsp15 (NendoU), (9) nsp16 (O-MT), (10) spike (S) and (11) nucleocapsid (N). Phylogenetic trees were inferred using the maximum likelihood method implemented in the PhyML program (v.3.0)38 (link), using the generalized time reversible substitution model and subtree pruning and regrafting branch swapping. Bootstrap support values were calculated from 1,000 pseudo-replicate trees. The best-fitting model of nucleotide substitution was determined using MEGA (v.5)39 (link). Amino acid identities among sequences were calculated using the MegAlign program implemented in the Lasergene software package (v.7.1, DNAstar).
Full text: Click here
Publication 2020
Amino Acid Sequence Base Sequence Coronavirus Cytokinesis DNA Replication Endopeptidases Exons Genes Genes, Viral Genome nidoviral uridylate-specific endoribonuclease Nucleocapsid Nucleotides Open Reading Frames Trees Viral Genome
Clinical specimens were tested with an rRT-PCR assay that was developed from the publicly released virus sequence. Similar to previous diagnostic assays for severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), it has three nucleocapsid gene targets and a positive control target. A description of this assay13 and sequence information for the rRT-PCR panel primers and probes14 are available on the CDC Laboratory Information website for 2019-nCoV.15
Publication 2020
Biological Assay Diagnosis Genes Middle East Respiratory Syndrome Coronavirus Nucleocapsid Oligonucleotide Primers SARS-CoV-2 SARS Coronavirus Severe acute respiratory syndrome-related coronavirus
The day before infection, VeroE6 cells were seeded at 104 cells/well into 96-well plates. Plasma samples and antibodies were serial diluted in BA-1, consisting of medium 199 (Lonza) supplemented with 1% BSA and 1× penicillin/streptomycin. Next, the diluted samples were mixed with a constant amount of SARS-CoV-2 and incubated for 60 min at 37°C. The plasma/antibody/virus mix was then directly applied to VeroE6 cells (MOI of ∼0.1 PFU/cell; n = 3) and incubated for 18–20 h at 37°C. This amount of virus gave 30% to 50% infected cells at the end of the assay. Cells were subsequently fixed by adding an equal volume of 7% formaldehyde to the wells, followed by permeabilization with 0.1% Triton X-100 for 10 min. After extensive washing, cells were incubated for 1 h at RT with blocking solution of 5% goat serum in PBS (Jackson ImmunoResearch; catalog no. 005–000-121). A rabbit polyclonal anti-SARS-CoV-2 nucleocapsid antibody (GeneTex; catalog no. GTX135357) was added to the cells at 1:500 dilution in blocking solution and incubated at 4°C overnight. Alternatively, J2, a mouse monoclonal anti-dsRNA antibody (Scicons; catalog no. 10010500) was added to the cells under similar conditions to detect virus infected cells. Goat anti-rabbit Alexa Fluor 594 (Life Technologies; catalog no. A-11012) and goat anti-mouse Alexa Fluor 488 (Life Technologies; catalog no. A-11001) were used as a secondary antibodies at a dilution of 1:2,000. Nuclei were stained with Hoechst 33342 (Thermo Fisher Scientific; catalog no. 62249) at a 1:1,000 dilution. Images were acquired with a fluorescence microscope and analyzed using ImageXpress Micro XLS (Molecular Devices). Using uninfected cells as a control, we estimated that infection could be reliably quantified if ∼0.7% of cells or more were infected.
Full text: Click here
Publication 2020
Alexa594 alexa fluor 488 Antibodies Antibodies, Anti-Idiotypic Biological Assay Cell Nucleus Cells Formaldehyde Goat HOE 33342 Immunoglobulins Infection Medical Devices Microscopy, Fluorescence Mus Nucleocapsid Penicillins Plasma Rabbits RNA, Double-Stranded SARS-CoV-2 Serum Streptomycin Technique, Dilution Triton X-100 Virus
The day prior to infection VeroE6 cells were seeded at 12,500 cells/well into 96-well plates. Antibodies were serially diluted in BA-1, mixed with a constant amount of SARS-CoV-2 (grown in VeroE6) and incubated for 60 min at 37°C. The antibody-virus-mix was then directly applied to VeroE6 cells (MOI of ~0.1 PFU/cell). Cells were fixed 18 hours post infection by adding an equal volume of 7% formaldehyde to the wells, followed by permeabilization with 0.1% Triton X-100 for 10 min. After extensive washing, cells were incubated for 1 hour at room temperature with blocking solution of 5% goat serum in PBS (catalog no. 005–000-121; Jackson ImmunoResearch). A rabbit polyclonal anti-SARS-CoV-2 nucleocapsid antibody (catalog no. GTX135357; GeneTex) was added to the cells at 1:500 dilution in blocking solution and incubated at 4°C overnight. A goat anti-rabbit AlexaFluor 594 (catalog no. A-11012; Life Technologies) at a dilution of 1:2,000 was used as a secondary antibody. Nuclei were stained with Hoechst 33342 (catalog no. 62249; Thermo Scientific) at a 1:1,000 dilution. Images were acquired with a fluorescence microscope and analyzed using ImageXpress Micro XLS and MetaXpress software (Molecular Devices, Sunnyvale, CA). All statistical analyses were done using Prism 8 software (GraphPad).
Publication 2020
Antibodies Antibodies, Anti-Idiotypic Cell Nucleus Cells Formaldehyde Goat HOE 33342 Immunoglobulins Infection Medical Devices Microscopy, Fluorescence Nucleocapsid prisma Rabbits SARS-CoV-2 Serum Technique, Dilution Triton X-100 Virus
The day prior to infection VeroE6 cells were seeded at 12,500 cells/well into 96-well plates. Antibodies were serially diluted in BA-1, mixed with a constant amount of SARS-CoV-2 (grown in VeroE6) and incubated for 60 min at 37°C. The antibody-virus-mix was then directly applied to VeroE6 cells (MOI of ~0.1 PFU/cell). Cells were fixed 18 hours post infection by adding an equal volume of 7% formaldehyde to the wells, followed by permeabilization with 0.1% Triton X-100 for 10 min. After extensive washing, cells were incubated for 1 hour at room temperature with blocking solution of 5% goat serum in PBS (catalog no. 005–000-121; Jackson ImmunoResearch). A rabbit polyclonal anti-SARS-CoV-2 nucleocapsid antibody (catalog no. GTX135357; GeneTex) was added to the cells at 1:500 dilution in blocking solution and incubated at 4°C overnight. A goat anti-rabbit AlexaFluor 594 (catalog no. A-11012; Life Technologies) at a dilution of 1:2,000 was used as a secondary antibody. Nuclei were stained with Hoechst 33342 (catalog no. 62249; Thermo Scientific) at a 1:1,000 dilution. Images were acquired with a fluorescence microscope and analyzed using ImageXpress Micro XLS and MetaXpress software (Molecular Devices, Sunnyvale, CA). All statistical analyses were done using Prism 8 software (GraphPad).
Publication 2020
Antibodies Antibodies, Anti-Idiotypic Cell Nucleus Cells Formaldehyde Goat HOE 33342 Immunoglobulins Infection Medical Devices Microscopy, Fluorescence Nucleocapsid prisma Rabbits SARS-CoV-2 Serum Technique, Dilution Triton X-100 Virus

Most recents protocols related to «Nucleocapsid»

Example 6

For studies here, the next generation hAd5 [E1-, E2b-, E3-] vector was used (FIG. 1c) to create viral vaccine candidate constructs. As shown in FIG. 8d-h, a variety of constructs were created:

FIG. 8(d): S WT: S protein comprising 1273 amino acids and all S domains: extracellular (1-1213), transmembrane (1214-1234), and cytoplasmic (1235-1273) (Unitprot PODTC2);

FIG. 8(e): S RBD-ETSD: S Receptor Binding Domain with an Enhanced T-cell Stimulation Domain (ETSD);

FIG. 8(f): S Fusion: S optimized to enhance surface expression and display of RBD;

FIG. 8(g): N-ETSD: The nucleocapsid (N) sequence with the ETSD; and

FIG. 8(h): Bivalent S-Fusion+N-ETSD;

S-WT+N-ETSD and S RBD-ETSD+N-ETSD constructs were also produced, but are not shown.

Full text: Click here
Patent 2024
Amino Acids Cloning Vectors Cytoplasm Nucleocapsid spike protein, SARS-CoV-2 T-Cell Receptor T-Lymphocyte Viral Vaccines
The instructor provided to the students a brief introduction
to the most important features of the structure of SARS-CoV-2. The
four major structural proteins are displayed: the envelope (E), membrane
(M), nucleocapsid (N), and spike (S) proteins (Figure 1).7 (link)It is highlighted that spike protein (approximately 180–200
kDa) is the surface glycoprotein anchored to the viral membrane that
plays an essential role when the infection process of SARS-CoV-2 takes
place. This protein is a trimer of three identical protomers (Figure 2). Each protomer
contains three segments: a short intracellular tail (IC), a transmembrane
anchor (TM), and a large ectodomain that extends outward from the
virus which is coated with sugar chains to hide the virus from the
immune system8 (link) and comprises S1 and S2
subunits.
Next, the students are invited to study the ectodomain by analyzing
the requested structural features that they must observe manipulating
PyMOL.
Although hundreds of structures of this spike protein
are already
available in the Protein Data Bank, the one with the code 7DWY(9 (link)) has been selected and must be loaded in a PyMOL session.
They are encouraged to distinguish the four different levels of the
protein structures: primary, secondary, tertiary, and quaternary,
changing the representation of the molecule from lines or wireframe
to cartoon.
They must learn how to select individual residues
or different
chains, how to change their colors, how to generate objects, how to
show and hide different parts of the protein, how to measure distances
and angles for bonds, and how to generate surfaces.
They have
to realize that the spike protein is a complex of three
identical chains. A schematic illustration of the spike protein (Figure 3) is given to the
students, and they must recognize every single domain in the ectodomain,
extracting them as different objects and coloring them in the suggested
color.
The S1 subunit has an N-terminal
domain (NTD) and a receptor-binding
domain (RBD) located in the C-terminal domain, which is implied in
recognition and binding to the host cell receptor. S2 consists of
the fusion peptide (FP), two heptad repeats 1 (HR1 and HR2) which
operate the fusion of viral and host membranes, a transmembrane domain
(TM), and a cytoplasmic tail (CT).
When different species of
coronavirus are compared, the S2 subunit
is highly conserved, but the sequence of the S1 subunit varies greatly.
S1 and S2 are connected to the S1/S2 cleavage site in which specific
proteases act. The cleavage transforms the spike protein into a fusion
competent form that suffers several conformational changes and allows
it to anchor to the host membrane leading to the membrane fusion.10 (link)
Full text: Click here
Publication 2023
Carbohydrates Cells COVID 19 Cytokinesis Cytoplasm Membrane Fusion Membrane Glycoproteins M protein, multiple myeloma Nucleocapsid Peptides Proteins Protein Subunits Protomers Protoplasm SARS-CoV-2 Student Tail Tissue, Membrane Virus

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Actins alexa 568 alexa fluor 488 Alexa Fluor 647 anti-IgG Antibodies Biopharmaceuticals DDIT3 protein, human Goat isononanoyl oxybenzene sulfonate Light Mus Nucleocapsid Rabbits RNA, Double-Stranded SARS-CoV-2 Trp-Ser- His-Pro-Gln-Phe-Glu-Lys
To measure viral load in participants with COVID-19 and rule out asymptomatic infection in controls, quantitative reverse transcription PCR in all mid-turbinate swabs collected at enrolment using United States Centers for Disease Control and Prevention primers and probes designed for the detection of SARS-CoV-2 was performed [16 (link)]. High viral load was defined as a cycle threshold value for the detection of the coronavirus nucleocapsid gene region 1 below the median of all samples collected at enrolment (day 1) from SARS-CoV-2-infected participants.
Publication 2023
Coronavirus Infections COVID 19 Genes Infection Control Nucleocapsid Oligonucleotide Primers Reverse Transcription SARS-CoV-2 Turbinates

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
COVID 19 Genes Nucleocapsid Patients SARS-CoV-2

Top products related to «Nucleocapsid»

Sourced in Switzerland, Germany, United States, Italy
The Elecsys Anti-SARS-CoV-2 is a laboratory equipment product designed for the detection of antibodies against the SARS-CoV-2 virus. It is intended for use as an aid in determining the immune response to the SARS-CoV-2 virus.
Sourced in Germany, United States, United Kingdom, France, Spain, Japan, China, Netherlands, Italy, Australia, Canada, Switzerland, Belgium
The QIAamp Viral RNA Mini Kit is a laboratory equipment designed for the extraction and purification of viral RNA from various sample types. It utilizes a silica-based membrane technology to efficiently capture and isolate viral RNA, which can then be used for downstream applications such as RT-PCR analysis.
Sourced in Germany, United States, United Kingdom, Netherlands, Spain, Japan, Canada, France, China, Australia, Italy, Switzerland, Sweden, Belgium, Denmark, India, Jamaica, Singapore, Poland, Lithuania, Brazil, New Zealand, Austria, Hong Kong, Portugal, Romania, Cameroon, Norway
The RNeasy Mini Kit is a laboratory equipment designed for the purification of total RNA from a variety of sample types, including animal cells, tissues, and other biological materials. The kit utilizes a silica-based membrane technology to selectively bind and isolate RNA molecules, allowing for efficient extraction and recovery of high-quality RNA.
Sourced in Switzerland, Germany, United States, Canada
The Elecsys Anti-SARS-CoV-2 assay is a laboratory test designed to detect antibodies against the SARS-CoV-2 virus. It is a qualitative immunoassay that uses electrochemiluminescence technology to measure the presence of these antibodies in human serum or plasma samples.
Sourced in Switzerland, Germany, United States, Italy
The Elecsys® Anti-SARS-CoV-2 S is an immunoassay for the quantitative determination of antibodies to the SARS-CoV-2 spike (S) protein in human serum and plasma.
Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Sourced in United States, Germany, United Kingdom, Japan, China, Canada, Italy, Australia, France, Switzerland, Spain, Belgium, Denmark, Panama, Poland, Singapore, Austria, Morocco, Netherlands, Sweden, Argentina, India, Finland, Pakistan, Cameroon, New Zealand
DAPI is a fluorescent dye used in microscopy and flow cytometry to stain cell nuclei. It binds strongly to the minor groove of double-stranded DNA, emitting blue fluorescence when excited by ultraviolet light.
Sourced in United States, Ireland
The SARS-CoV-2 IgG assay is a laboratory equipment product designed to detect the presence of IgG antibodies to the SARS-CoV-2 virus in human serum or plasma samples. The assay provides a qualitative measurement of the IgG immune response to the virus.
Sourced in Switzerland, Germany, France
The Elecsys Anti-SARS-CoV-2 immunoassay is an in vitro diagnostic test used to detect antibodies against the SARS-CoV-2 virus. The test is designed to aid in the determination of the immune response to the SARS-CoV-2 virus.

More about "Nucleocapsid"

The nucleocapsid (N) protein is a critical structural component of viruses like SARS-CoV-2, the causative agent of COVID-19.
This N protein encapsulates the viral genome and plays a pivotal role in viral assembly and replication.
Researchers studying the nucleocapsid can leverage PubCompare.ai's powerful tools to streamline their workflows.
PubCompare.ai's platform allows researchers to easily locate relevant protocols from literature, preprints, and patents.
By utilizing AI-driven comparisons, researchers can identify the most reproducible and accurate methods for nucleocapsid analysis.
This optimization of nucleocapsid research workflows can lead to enhanced overall productivity.
The Elecsys Anti-SARS-CoV-2 and Elecsys® Anti-SARS-CoV-2 S assays are examples of serological tests that can detect antibodies against the SARS-CoV-2 nucleocapsid protein.
The QIAamp Viral RNA Mini Kit and RNeasy Mini Kit are commonly used for viral RNA extraction, while the TRIzol reagent is a popular method for total RNA isolation.
DAPI, a fluorescent dye, can be used to visualize the nucleocapsid structure.
By incorporating synonyms, related terms, abbreviations, and key subtopics, researchers can more effectively navigate the complexities of nucleocapsid research and leverage the cutting-edge tools offered by PubCompare.ai.
This comprehensive approach can help optimize workflows, enhance productivity, and drive advancements in the understanding and analysis of this crucial viral component.